information Attachment 1 REIT Establishment Agreement Attachment 2 Summary of the appraisal report Attachment 3 Others such as the financial statements of the income guarantor Attachment 4 Financial statements
% Power Plant Business3/ 568 781 812 43% 4% 2,559 3,088 21% Bio-Based Product Business4/ 131 159 132 1% -17% 326 529 62% Resource Business5/ 71 44 16 -77% -62% 323 286 -11% Others (0.3) (35) (30) N/A 13% 99
. Kunthong Udommahantisuk 9,000,000 0.75 10 Mr. Sirisak Wongjitwootthikai 7,906,100 1.09 10 Mrs. Pitchaya Poonlarb 8,000,000 0.66 11 Others 278,825,760 38.52 11 Others 286,762,966 23.77 Total 723,850,760
Others 278,825,760 38.52 11 Others 286,762,966 23.77 Total 723,850,760 100.00 Total 1,206,449,039 100.00 1.2. Type of Investor The Company will issue and allocate the newly issued ordinary shares to offer
. Kunthong Udommahantisuk 9,000,000 0.75 10 Mr. Sirisak Wongjitwootthikai 7,906,100 1.09 10 Mrs. Pitchaya Poonlarb 8,000,000 0.66 11 Others 278,825,760 38.52 11 Others 286,762,966 23.77 Total 723,850,760
% Bio-Based Products Business4/ 339 510 -34% 136 150% 848 330 157% Natural Resources Business5/ 60 (1,227) 105% 145 -59% (1,166) 122 N/A Others (71) (90) 22% (94) 25% (161) (170) 5% Profit attributable to
, including media and telecommunication business, technology business and others. In addition to his business management experience, he also held positions in governmental agencies such as Executive Council of
1 August 17, 2018 Subject: Capital Increase for Offering for Sale to Specific Investors (Private Placement), Connected Transaction, Amendments to Articles of Association/Objectives of the Company and Determination of the Date of Extraordinary General Meeting of Shareholders No. 1/2018 To: President The Stock Exchange of Thailand Enclosures: 1. Information Memorandum on the Offering of Newly Issued Ordinary Shares to Specific Investors (Private Placement) at the Offering Price with a Discount of...
% อื่นๆ 2.53% Biotechnology, 35.20% Health Care Equipment & Supplies, 33.80% Life Sciences Tools & Services, 14.90% Health Care Technology, 11.10% Pharmaceuticals, 3.30% Others, 0.80% Cash, 0.80% LHHEALTH-A
JV 13 7 80% (2) 6 (0) 3,284% Others (FiberVisions, PHP China, Mexico) 1 5 (75)% 0 0 1 (84)% 1 74% PTA JV, IVL started consolidating Polyprima Indonesia result since 4Q18. IVL has 100% ownership since